Browse Antineoplastic agents topic

Intellectual property subtopic

Articles 1-30 out of 30 article(s) Title Author Type Date Words Immunotherapy-Based Provisional Patents Mark Significant Discovery. Mar 1, 2009 530 Power3 Medical Products in Collaboration with StemTroniX, Inc., to Identify and Monitor Autologous Adult Stem Cells for Use in Stem Cell Therapy using Protein Biomarkers. Oct 9, 2008 484 Nanobiotix Announces Issue of European Patent Protecting Its nanoXray(TM) Anticancer Platform. Sep 22, 2008 422 Fujirebio Diagnostics Issued Patent for Ovarian Cancer Biomarker. Oct 31, 2007 491 Optimata Granted Patent For Granulopoiesis-Modelling System, Can Optimize Cancer Drug Development With Less Toxicity. Sep 11, 2007 465 Quo vadis, Novartis? It's kind of ironic that Novartis, a company known for its ethical stance and for helping the poor in developing countries through aid and international assistance programs, should be on the wrong end of a judgement over patent laws in India. Lampard, Graham Editorial Sep 1, 2007 446 Cool work from Piramal. Brief article Sep 1, 2007 234 GammaCan Discovers Anti-Angiogenic Properties in Plasma-Derived IgG. Jun 28, 2007 832 Affitech Moves to Further Strengthen Human Antibody Intellectual Property Position. May 2, 2007 322 Lpath granted patent protection for anti-cancer anti-S1P antibody. Apr 1, 2007 493 Optimata Granted Patent for Modeling Thrombopoiesis. Dec 19, 2006 434 Dartmouth College obtains United States patent. Nov 1, 2006 81 New Patent Granted for OXiGENE's Lead Therapeutic Candidate for Oncology, Combretastatin A4P (CA4P). May 5, 2006 652 Affitech Renews Exclusive Worldwide Phage Display License From DKFZ; 'Breitling' Patents Hold Key Position in Human Antibody Discovery Field. Apr 9, 2006 332 New Patent Awarded for OXiGENE's Lead Therapeutic Candidate, Combretastatin A4 Prodrug; Intellectual Property Portfolio Strengthened by Method of Synthesis and Composition of Matter Patent Coverage Through 2019. Mar 29, 2006 648 Semafore awarded patent covering PI3K prodrug technology targeting central cell signaling pathway. Sep 1, 2005 897 Oncolytic technology patent awarded to VirRx and Introgen. Jan 1, 2004 386 Peregrine obtains tumor treatment patent. Jan 1, 2004 597 SuperGen obtains United States patent. Brief Article Sep 1, 2003 117 Favorable news on anti-cancer patents lifts biotech company. (Wall Street West). Darmiento, Laurence Brief Article Jul 14, 2003 229 Mount Sinai School of Medicine obtains United States patent. Brief Article Jun 1, 2003 87 Patent lawsuit. (Week in Review). Brief Article Mar 3, 2003 123 Genzyme Molecular Oncology receives breast and ovarian cancer patent. Mar 1, 2003 448 Oregon Health & Science University issued vitamin D tumor patent. Mar 1, 2003 676 Vlaams Interuniversitair Instituut obtains United States patent. Brief Article Mar 1, 2003 64 Oklahoma Medical Research Foundation obtains United States patent. Brief Article Feb 1, 2003 85 Introgen obtains patent for p53 targeted chemotherapy. Oct 1, 2002 468 Hybridon announces issuance of a patent covering CpG oligonucleotides. Brief Article Aug 1, 2002 302 TECHNICLONE ISSUED PATENT ON VASOPERMEATION ENHANCEMENT. Feb 1, 2000 540 NaPro receives paclitaxel administration patent. May 1, 1998 89